GlassScriptPhysician profile
Emily Tomaselli
NPI 1790167039
$1,913.70
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $179 · 2021: $186 · 2022: $144 · 2023: $199 · 2024: $507 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $634.64 | 2019-2025 | Clareon, Argos, Rocklatan |
| Rxsight INC | $340.85 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $264.00 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $124.99 | 2021 | |
| Glaukos Corporation | $122.52 | 2019 | |
| New World Medical,INC. | $116.38 | 2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Rayner Intraocular Lenses Limited | $72.78 | 2023-2024 | Omidria, Rayone Spheric, Rayone Emv |
| Mindray Ds USA, INC. | $42.55 | 2025 | A7 Anesthesia System |
| Abbvie INC. | $29.31 | 2023 | Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $29.04 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $23.71 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $23.67 | 2024 | |
| Harrow Eye, LLC | $23.49 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $19.97 | 2023 | Cequa |
| Biotissue Holdings INC. | $17.77 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $15.07 | 2025 | Xiidra, Miebo |
| Sight Sciences, INC. | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Tomaselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.